THE NOW Inflection Point | 2025 VBEF Future Healthcare 100 Summit Unveils Full Theme Framework

In physics, a critical point often heralds a pivotal moment of breaking boundaries. Water can freeze at 0°C and vaporize at 100°C; in the critical state, even slight changes in external conditions can trigger a phase transition, achieving a qualitative leap.

The healthcare industry is currently in a highly symbolic state—a “tipping point.”

In 2024, China’s healthcare industry exhibited multi-dimensional development trends under the interplay of policy guidance, market transformation, payment innovation, and geopolitical factors. The combined net profit attributable to shareholders of 496 A-share listed healthcare companies decreased by 8.64% year-on-year, reflecting an overall decline in profitability among listed healthcare firms. Meanwhile, the number and total value of primary market investments and financings continued to contract. At the same time, favorable policies for innovative drugs were frequently introduced; driven by the dual forces of population aging and consumption upgrading, China’s original innovative pharmaceuticals have begun to stand out in the wave of global expansion.

Industries shrouded in uncertainty always harbor the unknown, the infinite, challenges, and opportunities. All stakeholders can do is embrace “THE NOW”—focus on the present and act immediately.

Thus, we can see that in 2024:

Original innovative products are rapidly breaking through: 43 domestically developed innovative drugs and 66 innovative medical devices have been approved for market launch. “China’s first” and “global debut” have become frequent occurrences, with successful expansion into international markets. Meanwhile, multi-level collaborations among ecosystem enterprises in the industry are intensifying; VCBeat facilitated 4,241 partnership connections for 1,036 companies throughout the year.

Every innovator is forging ahead, accumulating the power for phase change in the subtle details, to navigate this transitional period that appears dim yet brims with hope, and ultimately welcome the long-awaited breakthrough.

As a deeply engaged partner to the industry,VCBeat’s VBEF Future Healthcare & Pharma Top 100 Exhibition (hereinafter referred to as “VBEF”) has accompanied us for a decade. Together, we have witnessed the Chinese healthcare industry’s journey toward innovation, characterized by surging creative momentum and a unique appeal on the global stage. In 2025, we will continue to uphold this mission, ensuring that innovations in China’s healthcare industry are seen, recognized, and in demand.

On May 9–10, the 2025 VBEF Future Healthcare & Pharma Top 100 Expo, themed “THE NOW: Tipping Point,” was held as scheduled at the Suzhou International Expo Center in China.。

WeInnovative Showcase and Deep Linkingas the core, set up“Forum + Awards + Exhibition + Report + Resource Matchmaking”Five Major Segments, Continuously Providing New Channel Expansion Opportunities for Innovative Products, and Offering a Platform for All Stakeholders in the IndustryComprehensive, multi-level needs including efficient investment and financing, BD collaborations, industrial and supply chain transactions, finished product trading, and overseas market expansionthe optimal setting.

Authoritative Rankings Released, In-Depth Trend Analysis:2025 Future Healthcare 100 Awards: Identifying the True Core Forces; 2 Main Forums Focusing on Trend Strategy and Innovation, 4 Featured Forums Analyzing Cutting-Edge Technologies and Market Trends, 20+ Thematic Forums Discussing Hot Topics to Uncover New Opportunities in the Future of Healthcare, with 300+ Industry Leaders Sharing Their Insights!

Global Collaboration, Direct Transactions through Supply Chain Partnerships:Featuring eight themed exhibition zones, the event facilitates direct dialogue with over 2,000 medical device manufacturers, pharmaceutical companies, supply chain enterprises, and distributors/agents from more than 20 countries and regions, enabling efficient exploration of business collaboration and transaction opportunities!

High-Value Resources, Efficient Connections:15,000 sqm exhibition space, 150+ exhibitors, 400+ innovative product launches, alongside N+ networking activities including matchmaking sessions, closed-door meetings, and project roadshows, facilitating efficient and precise connections and collaborations through diverse events!

The tipping point is the breaking point! Confusion and breakthrough alternate; troughs and peaks cycle in succession. Those who pierce through the fog are rewriting the rules: leveling obstacles with technology, shattering inertia with innovative concepts, breaking free from the cyclical patterns of emotional fluctuations and industry transformation, and amplifying China’s voice in this new phase and moment. Here, you will find interpretations of macroeconomic trends and industrial innovation, as well as exemplary solutions and practices at the tipping point.

Hot Topics:

The Evolution of the Healthcare Payment System

Analysis of Global and Localized Market Strategies

Interpretation of Policies on Medical Insurance Cost Containment, Centralized Procurement, and Anti-Corruption

Shifts in Industrial Demand Amid Population Aging and Declining Birth Rates

Investment and Financing Transformation and Industrial Reshaping in the New Era

Strategic Exploration of Digitalization: From Cost Reduction and Efficiency Enhancement to Value Creation

Transformation of Collaboration Models Between Enterprises and Distributors in the New Era

Building an Intellectual Property Strategy for Medical Devices in Global Competition

Transformations and Opportunities in China's Healthcare Sector Amid Complex Geopolitical Relations

Innovative Translation Practices of Medical Institutions Amid Opportunities for Integrated Development of Medicine and Engineering

With the rapid emergence of innovative medical devices, the accelerated commercialization by enterprises, and the frequent entry of medical device products into international markets, upstream suppliers are undergoing transformation and reshaping in areas such as supply chain construction, independent research and development of core components, and the establishment of stable supply chain relationships. Full-chain innovation, spanning from R&D to production, has become an inevitable trend. Meanwhile, driven by the need to ensure quality while accelerating development in the medical device sector, the rise of third-party CDMO services has further accelerated the translation and commercialization of medical devices.

Hot Topics:

Key Elements and Pathways for Source Innovation in Medical Devices

Synergistic Development of Source Innovation and Manufacturing from a CXO Perspective

Regulatory Trends in the High-Quality Development of Medical Device Oversight in China

Breakthroughs and Innovations in Upstream Medical Imaging Components: CT Detectors, CT X-ray Tubes, and More

Safeguarding Supply Chain Security: Cost Reduction, Efficiency Enhancement, and the Code to Domestic Substitution Amidst Centralized Procurement

As a groundbreaking “creation” technology, biomanufacturing is regarded as one of the most critical new tracks and business models driving new-quality productive forces. Future industries represented by biomanufacturing have garnered significant attention from all sectors, with government encouragement and fiscal support aimed at proactively targeting the global technological frontier, seizing major trends, and securing strategic advantages. In essence, biomanufacturing is a future-oriented industry, a “strategic high ground” that major powers are bound to compete for, and a technological pinnacle that stakeholders across the industrial landscape are striving to occupy.

# Trending Topics：

Sharing of DuPont’s Global Development Experience

Revelations from the Wave of U.S. Biomanufacturing

Analysis of Global Venture Capital Trends in Biomanufacturing

Major Release of the Report on the Global Innovation Ecosystem for Biomanufacturing

Analysis of Novonesis’s Localization Strategy as a Global Enzyme Giant

More featured forums will be announced in due course. Stay tuned for updates.

In recent years, China’s healthcare sector has undergone multi-dimensional innovation and upgrading, driven by policy support, technological breakthroughs, and capital investment. For instance, the role of AI in medical settings has evolved from a supportive tool to a core engine; gene and cell therapies have achieved industrialization; synthetic biology has progressed from a technical concept to large-scale production; and the high-end medical device sector has made significant breakthroughs in both import substitution and globalization.

2025 VBEF: VCBeat will host 20+ thematic forums across specialized sectors, showcasing China’s accumulated innovations in technology, products, and services, as well as insights into emerging trends.

More hot topics and detailed agendas for the popular sub-sector forums will be announced sequentially. Stay tuned.

In addition to the forum, VBEF focuses on supply-demand dynamics and hosts a series of matchmaking activities concurrently:

VBEF Innovation Zone:Eight exhibition zones have been established, covering the Innovative Medical Devices Exhibition, Medical Device Design and Manufacturing Exhibition, Digital Health and Services Exhibition, Biomanufacturing Special Exhibition, Life Science Instruments Exhibition, Health Consumer Products Collection Exhibition, Regional Government and Industrial Park Exhibition, and International Exhibition Zone. These zones aim to provide enterprises with a professional platform for display and exchange, jointly promoting industry development.

Partner Matchmaking Session:Facilitating connections to high-quality projects and upstream/downstream partners for international embassies, healthcare enterprises, investors, innovation centers, research institutes, and other institutions.

Government-Enterprise Exchange Meeting:Leveraging the government’s superior resources to precisely identify corporate pain points and needs, rapidly define solutions, and facilitate swift implementation and growth for enterprises.

Hot Sector Project Pitch:Bridging venture capital and startups, facilitating exchanges between innovative healthcare enterprises, research institutes with project outcomes, leading investment institutions, and enabling industrial parks, while providing a public showcase platform for outstanding domestic and international healthcare innovation projects.

A series of distinctive networking and matchmaking events, including overseas product selection sessions, new product launches, training workshops, delegation visits, and VIP dinners, will be announced in due course.

China’s First Innovation Healthcare List for Private Companies, Selecting the Chinese Innovators Who Truly Represent the Future of Healthcare.

VCBeat annually releases the "Report on the Growth Potential of the Top 100 Companies" based on that year’s Future Healthcare 100 list. By leveraging data to illuminate corporate growth trajectories, the report summarizes patterns of enterprise development and trends in industry evolution, providing valuable references for healthcare companies and entrepreneurs.

Meanwhile, to better analyze the drivers and current development status of popular healthcare sub-sectors both domestically and internationally, VCBeat will release in-depth industry reports on three key sub-sectors. These reports will be based on a review of prominent healthcare segments and aligned with the topics and forum structure of this year’s VBEF.

This report focuses on the theme of “Localization of High-End Ophthalmic Equipment,” analyzes commercialization strategies for various products, and reflects the current development status, maturity levels, and future trends across different product segments. It aims to provide insights for enterprises’ product innovation and commercialization strategies, while also serving as a basis for product evaluation and investment decision-making for stakeholders both within and outside the industry.

This white paper focuses on “Innovation in Cardiac Electrophysiology Ablation Technologies.” It examines the impact of emerging and evolving innovative technologies on the electrophysiology industry, and conducts an in-depth analysis of the technological products and marketization strategies of leading companies in cardiac electrophysiology ablation, highlighting how these industry leaders drive sector development through innovation.

This white paper focuses on the theme of “Digital and Intelligent Laboratory Construction,” providing a comprehensive analysis of how to upgrade laboratory software, instruments and equipment, furniture, and spatial facilities through digital and intelligent technologies. It examines the conditions and resource investments required for such upgrades, explores how the entire digital and intelligent supply chain empowers laboratory development, and establishes a “benchmark model” for digital and intelligent laboratory construction by analyzing solutions from leading suppliers in this field.

Exhibition Name:2025 VBEF Future Healthcare & Pharma Top 100 Expo

Exhibition Dates:May 9–10, 2025 (May 8 is the exhibition registration day)

Exhibition Venue:Suzhou International Expo Center

Exhibition Floor Plan

Exhibition partnerships, event registration, and the Top 100 selection are now fully underway. For details, please contact the Organizing Committee.